INFILTRATING BLADDER UROTHELIAL CARCINOMA SARCOMATOID VARIANT
Clinical trials for INFILTRATING BLADDER UROTHELIAL CARCINOMA SARCOMATOID VARIANT explained in plain language.
Never miss a new study
Get alerted when new INFILTRATING BLADDER UROTHELIAL CARCINOMA SARCOMATOID VARIANT trials appear
Sign up with your email to follow new studies for INFILTRATING BLADDER UROTHELIAL CARCINOMA SARCOMATOID VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo targets Tough-to-Treat bladder cancer
Disease control OngoingThis study is testing whether a combination of two drugs, pemetrexed and avelumab, can help control advanced bladder cancer that has spread and has a specific genetic feature (MTAP-deficient). The trial is for people whose cancer has worsened after prior treatment. Researchers wa…
Matched conditions: INFILTRATING BLADDER UROTHELIAL CARCINOMA SARCOMATOID VARIANT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug duo tested before surgery for tough bladder cancers
Disease control OngoingThis early-stage study is testing the safety of a two-drug immunotherapy combination (durvalumab and tremelimumab) given before surgery to patients with aggressive bladder and related urinary tract cancers. The trial is specifically for patients who cannot receive the usual pre-s…
Matched conditions: INFILTRATING BLADDER UROTHELIAL CARCINOMA SARCOMATOID VARIANT
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC